Food and Drug Administration

October 8, 2009

SurModics' Drug Delivery to Release Lucentis for Macular Degeneration

Surmodics announces agreement with Genentech/Roche to combine proprietary drug delivery system with Lucentis (ranibizumab) for the treatment of wet macular degeneration.
December 8, 2009

Steroids Likely to Help Diabetes

Small study shows long-lasting effects of intravitreal steroids for the treatment of diabetic macular edeam, a common complication of diabetic retinopathy.
December 28, 2009

Iluvien® For Diabetic Macular Edema Has Eyes on FDA

Alimera's Iluvien proving effective in phase 3 clinical trials. Iluvien will release fluocinolone acetonide for the treatment of diabetic macular edema. Iluvien is an injectable extended release delivery system.
January 11, 2010

Evidence Based Medicine – Where's the Beef?

Evidence based medicine (EBM) gives us the proof that a new drug or treatment is valid and effective. The FDA provides a sound process by which treatments in the U.S. become evidence based.